AN2 Therapeutics, Inc. (ANTX) Tops Q2 EPS by 10c

AN2 Therapeutics, Inc. (NASDAQ: ANTX) reported Q2 EPS of ($0.21), $0.10 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on AN2 Therapeutics, Inc. (ANTX) click here.

You May Also Be Interested In

• Seaport Global Securities Downgrades JetBlue Airways (JBLU) to Neutral
• Onemeta reports 500% usage rise and $2.4M cash flow in H1 2026
• Nvidia to invest $1.5B in SB Energy for Ohio AI campus with OpenAI